New study on sepsis diagnostic market dominated by two segments, namely, conventional diagnostics and automated diagnostics. Automated diagnostics segment expected to grow at highest CAGR from 2018 to 2023.
Sepsis diagnostic market to grow at 9.1% CAGR and to reach US$ 613.9 Million by 2023 from US$ 396.6 Million in 2018. Geographically, sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, & RoW. Asia Pacific is expected to register highest growth rate during forecast period due to high prevalence of sepsis. Accurate detection of positive blood cultures, quick turnaround time, & reduced risk of contamination is contributing to growth of this segment.
Download Free Sample Papers of Sepsis Diagnostics Market spread across 193 Pages, Profiling 15 Companies and Supported with 130 Tables and 41 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=694372 .
Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive demand for sepsis diagnosis during study period. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.
“The blood culture media segment is expected to be the fastest-growing segment during the forecast period.”
Sepsis diagnostics market research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
Get Best Buy Discount on Sepsis Diagnostic Market with Forecast and Company Profiles at http://www.rnrmarketresearch.com/contacts/discount?rname=694372 .
Major players of sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).
- Sepsis diagnostic device manufacturers
- Clinical laboratories
- Hospitals and clinics
- Research institutes and clinical research organizations (CROs)
- Sepsis diagnostic device suppliers and distributors
- Blood culture media manufacturers
- Blood culture media distributors and suppliers
- Market research and consulting firms
More Information “Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User – Global Forecast to 2023” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=694372 .
This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.